Monoclonal antibody given to preterm babies may reduce wheeze later

No Comment 0 View

Preterm babies given the monoclonal antibody palivizumab to prevent respiratory syncytial virus (RSV) also appear less likely to develop recurrent wheeze, at least until the age of six, according to new research.



Source link

In : Health

About the author

Leave a Reply

Your email address will not be published. Required fields are marked (required)